Human IL-18 bioactivity in hematological malignancies with highly elevated serum IL-18 levels.
Takubo
T
T
Department of Clinical and Laboratory Medicine, Osaka City University Medical School, Osaka, Japan. m3542254@med.osaka-cu.ac.jp
Okura
H
H
Kumura
T
T
Nishiki
S
S
Kinoshita
Y
Y
Koh
K
K
Ohta
K
K
Yamane
T
T
Hino
M
M
Kamitani
T
T
Tatsumi
N
N
D000328:Adult; D000368:Aged; D002460:Cell Line / Q000187:drug effects / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006023:Glycoproteins / Q000097:blood / Q000494:pharmacology; D019337:Hematologic Neoplasms / Q000097:blood*; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D007371:Interferon-gamma / Q000378:metabolism; D020382:Interleukin-18 / Q000037:antagonists & inhibitors / Q000097:blood* / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000097:blood* / Q000494:pharmacology
D006023:Glycoproteins; D036341:Intercellular Signaling Peptides and Proteins; D020382:Interleukin-18; D009363:Neoplasm Proteins; C118370:interleukin-18 binding protein; D007371:Interferon-gamma